tiprankstipranks
DNAPrint Genomics Inc (DNAG)
OTHER OTC:DNAG
US Market

DNAPrint Genomics (DNAG) Financial Statements

10 Followers

DNAPrint Genomics Financial Overview

DNAPrint Genomics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; DNAPrint Genomics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 07Jun 07Mar 07Dec 06Sep 06
Income Statement-
Total Revenue$ 227.56K$ 476.99K$ 701.01K$ 525.65K$ 651.75K
Gross Profit$ -6.59K$ 85.74K$ 186.31K$ 180.91K$ 218.18K
EBIT$ -1.66M$ -1.46M$ -1.45M$ -1.74M$ -2.73M
EBITDA$ -1.51M$ -1.28M$ -1.01M$ -1.30M$ -2.21M
Net Income Common Stockholders$ -1.88M$ -1.70M$ 2.89M$ -3.86M$ -3.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 134.35K$ 507.97K$ 4.86M$ 8.50M$ 110.79K
Total Assets$ 3.11M$ 4.95M$ 6.68M$ 10.27M$ 4.39M
Total Debt$ 5.33M$ 5.68M$ 6.05M$ 7.28M$ 6.75M
Net Debt$ 5.19M$ 5.17M$ 1.19M$ -1.21M$ 6.63M
Total Liabilities$ 11.50M$ 11.97M$ 12.43M$ 13.98M$ 10.43M
Stockholders Equity$ -8.39M$ -7.02M$ -5.75M$ -3.71M$ -6.04M
Cash Flow-
Free Cash Flow$ -1.36M$ -1.21M$ -1.25M$ -485.77K$ -1.33M
Operating Cash Flow$ -1.36M$ -1.21M$ -1.25M$ -324.37K$ -1.24M
Investing Cash Flow$ 1.35M$ 2.01M$ 1.95M$ 393.24K$ -87.61K
Financing Cash Flow$ -338.03K$ -561.81K$ -1.03M$ 405.40K$ 103.25K
Currency in USD

DNAPrint Genomics Earnings and Revenue History

DNAPrint Genomics Debt to Assets

DNAPrint Genomics Cash Flow

DNAPrint Genomics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis